Why is Senores Pharma. falling/rising?

As of 07-Nov, Senores Pharmaceuticals Ltd is experiencing a price increase, currently at 822.30, reflecting a rise of 16.5 or 2.05%. The stock has recently hit a new 52-week and all-time high of Rs. 831.65 today, demonstrating strong performance with a 7.24% gain over the last two days. Additionally, it has outperformed its sector by 2.39%. The stock's performance over the past week shows a return of +6.82%, while it has achieved a remarkable +16.09% over the past month. The company has shown impressive financial health, with net sales growing at an annual rate of 85.60% and a net profit increase of 138.15%, contributing to positive investor sentiment and driving the stock's upward movement. In the broader market context, while the Sensex has declined by 0.86% over the past week, Senores Pharmaceuticals has significantly outperformed this benchmark, indicating strong investor confidence in the company relative to the overall market. The rising investor participation, evidenced by a 549.92% increase in delivery volume, further supports the stock's upward trajectory. The company's low debt-to-equity ratio and consistent positive quarterly results reinforce its stability and growth potential, making it an attractive option for investors despite the broader market's fluctuations.